Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 501684356

ARIH2 Mouse anti-Human, Clone: OTI1B2, liquid, TrueMAB™
SDP

Catalog No. 501684356
Encompass_Preferred
Change view
Click to view available options
Quantity:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-168-4356 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-168-4356 Supplier OriGene Supplier No. TA811978
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

E3 ubiquitin-protein ligase mediating ′Lys-48′-and ′Lys-63′-linked polyubiquitination and subsequent proteasomal degradation of modified proteins. May play a role in myelopoiesis.

Specifications

Antigen ARIH2
Applications Western Blot
Classification Monoclonal
Clone OTI1B2
Concentration 1 mg/mL
Conjugate Unconjugated
Formulation PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
Gene ARIH2
Gene Accession No. O95376
Gene Alias ARI2, TRIAD1
Gene Symbols ARIH2
Host Species Mouse
Immunogen Human recombit protein fragment corresponding to amino acids 201-493 of human ARIH2 produced in E.coli.
Purification Method Affinity Chromatography
Quantity 100 μL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 10425
Target Species Human
Content And Storage -20° C, Avoid Freeze/Thaw Cycles
Product Type Antibody
Form Liquid
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.